Showing results (251-260 of 398) with videos related to
Sort By:
Pageof 40
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 25, 2015
Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trialJeong Il Yu, Do Hoon Lim, Yong Chan Ahn, et al.Journal of Gastric Cancer|January 5, 2019
Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III TrialYoujin Kim, Kyoung-Mee Kim, Min Gew Choi, et al.Oncology|June 25, 2011
A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancerJun Ho Yi, Jeeyun Lee, Se Hoon Park, et al.Journal of Korean Medical Science|February 18, 2004
The outcomes of hypertransfusion in major ABO incompatible allogeneic stem sell transplantationSe Hoon Park, Mark Hong Lee, Se Hoon Lee, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2010
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapyKyoung Ha Kim, In-Gu Do, Hyeong Su Kim, et al.Journal of Gastric Cancer|July 20, 2016
The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III TrialYoujin Kim, Se Hoon Park, Kyoung-Mee Kim, et al.British Journal of Cancer|September 11, 2018
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinomaThomas Powles, Robert J Motzer, Bernard Escudier, et al.Cancer Chemotherapy and Pharmacology|December 11, 2008
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancerKyoung Ha Kim, Young Suk Park, Myung Hee Chang, et al.Clinical Genitourinary Cancer|June 7, 2025
Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Exploratory Analysis of the Asian Subpopulation in the THOR Phase 3 StudyNobuaki Matsubara, Yohann Loriot, Earle F Burgess, et al.Onkologie|February 25, 2011
Which patients benefit from preoperative chemoradiotherapy for intermediate staged rectal cancer?Won Sup Yoon, Won Park, Doo Ho Choi, et al.Pageof 40